info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Plasma Therapy Companies

Plasma therapy, also known as convalescent plasma therapy, involves using the plasma from individuals who have recovered from a specific infection to treat others. This therapeutic approach has been explored for various infectious diseases, including viral infections.

Plasma Therapy Key Companies

 


Latest Plasma Therapy Companies Update:

Octapharma


January 22, 2024: Published data from the WIL-31 study, marking a milestone in improving long-term care for severe von Willebrand disease (VWD) patients.January 9, 2024: Announced availability of Balfaxar® for warfarin reversal in urgent surgery and invasive procedures.


CSL (Australia)


April 2023: Received FDA approval for a new prefilled syringe of Hizentra for patients with primary immunodeficiency (PI) and chronic inflammatory demyelinating polyneuropathy (CIPD).


Grifols (Spain)


March 2022 Received European approvals for XEMBIFY, a 20% subcutaneous immunoglobulin (SCIG) for PI treatment.


List of Plasma Therapy Key companies in the market

  • BioLife Plasma Services (US)

  • Cambryn Biologics LLC (US)

  • Biotest (Germany)

  • CSL Ltd. (Australia)

  • Grifols International S.A. (Spain)

  • Kedrion S.p.A. (Italy)

  • LFB S.A (France)

  • Bio Products Laboratory Ltd. (U.K.)

  • China Biologic Products, Inc. (China)

  • Octapharma (Switzerland)

  • Arthrex, Inc. (US)

  • DePuy Synthes Companies (US)

  • Grifols S.A (Spain)

  • Global Stem Cells Group, Inc. (US)

  • Juventix Regenerative Medical LLC (U.S.)

  • Celling Biosciences, Inc. (U.S.)


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.